Time after surgery, month | 0–5 | 6–11 | 12–35 | 36–59 | 60- | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | % | n | % | n | % | n | % | n | % | p-value | |
Age at survey, year | < 0.001 | ||||||||||
Mean ± SDa | 48.9 ± 9.7 | 49.1 ± 8.3 | 49.5 ± 8.6 | 49.5 ± 6.8 | 53.6 ± 7.9 | ||||||
20–49 | 21 | 53.8 | 53 | 57.6 | 74 | 49.7 | 89 | 49.4 | 60 | 26.5 | |
50- | 18 | 46.2 | 39 | 42.4 | 75 | 50.3 | 91 | 50.6 | 166 | 73.5 | |
Age at diagnosis, year | |||||||||||
Mean ± SDa | 48.2 ± 9.7 | 48.1 ± 8.3 | 47.1 ± 8.3 | 45.2 ± 6.8 | 45.2 ± 8.1 | ||||||
Level of Education | 0.014 | ||||||||||
≤ middle school | 10 | 26.3 | 12 | 13.0 | 20 | 13.5 | 15 | 8.3 | 40 | 17.7 | |
≤ high school | 12 | 31.6 | 42 | 45.7 | 71 | 48.0 | 68 | 37.8 | 91 | 40.3 | |
≥ college | 16 | 42.1 | 38 | 41.3 | 57 | 38.5 | 97 | 53.9 | 95 | 42.0 | |
Living with spouse | 0.160 | ||||||||||
Yes | 31 | 79.5 | 75 | 81.5 | 121 | 81.2 | 161 | 89.4 | 184 | 81.4 | |
No | 8 | 20.5 | 17 | 18.5 | 28 | 18.8 | 19 | 10.6 | 42 | 18.6 | |
Stage (AJCC 7th) | 0.042 | ||||||||||
I | 20 | 51.3 | 42 | 45.7 | 78 | 52.7 | 111 | 61.7 | 107 | 47.6 | |
II | 16 | 41.0 | 38 | 41.3 | 50 | 33.8 | 61 | 33.9 | 93 | 41.3 | |
III | 3 | 7.7 | 12 | 13.0 | 20 | 13.5 | 8 | 4.4 | 25 | 11.1 | |
Type of Surgery | < 0.001 | ||||||||||
Breast conserving surgery | 28 | 71.8 | 64 | 69.6 | 116 | 77.9 | 115 | 63.9 | 104 | 46.0 | |
Mastectomy | 11 | 28.2 | 28 | 30.4 | 33 | 22.1 | 65 | 36.1 | 122 | 54.0 | |
Radiotherapy | < 0.001 | ||||||||||
Done | 28 | 71.8 | 69 | 75.0 | 125 | 83.9 | 121 | 67.2 | 129 | 57.1 | |
Not done | 11 | 28.2 | 23 | 25.0 | 24 | 16.1 | 58 | 32.2 | 96 | 42.5 | |
Chemotherapy | < 0.001 | ||||||||||
Done | 23 | 59.0 | 62 | 67.4 | 87 | 58.4 | 71 | 39.4 | 143 | 63.3 | |
Not done | 16 | 41.0 | 30 | 32.6 | 62 | 41.6 | 109 | 60.6 | 83 | 36.7 | |
Endocrine therapy | < 0.001 | ||||||||||
Done | 29 | 74.4 | 66 | 71.7 | 112 | 75.2 | 164 | 91.1 | 200 | 88.5 | |
Not done | 10 | 25.6 | 26 | 28.3 | 37 | 24.8 | 16 | 8.9 | 26 | 11.5 |